Actively Recruiting
Barts-MINOCA Registry
Led by Queen Mary University of London · Updated on 2025-11-18
3000
Participants Needed
1
Research Sites
324 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The last 15 years the introduction of primary angioplasty has radically improved outcomes for acute myocardial infarction (AMI). However, the system wide availability of prompt investigation has revealed an important group of patients where progress has stalled, the diagnosis is unclear and therapeutic approaches are uncertain. Myocardial infarction with non-obstructive coronary arteries (MINOCA) is found in 1 - 13% of all patients with a clinical diagnosis of AMI. These patients present a therapeutic predicament since coronary revascularization is not appropriate. Guidelines do not exist for their management - yet the condition is not benign - the 12-month prognosis, although better than obstructive coronary artery disease patients is still guarded with recent data suggesting many questions remain unanswered.
CONDITIONS
Official Title
Barts-MINOCA Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male and female patients aged 16 years and older
- Patients diagnosed with MINOCA or without a clear cause of troponin rise
You will not qualify if you...
- Patients younger than 16 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Barts Health NHS Trust
London, United Kingdom
Actively Recruiting
Research Team
D
Daniel Jones, MBBS, PhD
CONTACT
K
Krishnaraj Rathod, MBBS, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here